The intracellular signalosome of PD-L1 in cancer cellsDavid Escors, Grazyna Kochan|Signal Transduction and Targeted Therapy|2018Cited by 287
Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen‐specific regulatory T cells, and suppresses experimental inflammatory arthritisFrederick Arce, David Escors|Arthritis & Rheumatism|2010Cited by 66
Highly differentiated CD4 T cells Unequivocally Identify Primary Resistance and Risk of Hyperprogression to PD-L1/PD-1 Immune Checkpoint Blockade in Lung CancerMiren Zuazo-Ibarra, David Escors|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 26
Functional systemic CD4 immunity is a differential factor for clinical responses to PD-L1/PD-1 blockade therapy in lung cancerMiren Zuazo, David Escors|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 3